Publication February 1, 2016 by Michael Kinch · Published February 1, 2016 An overview of FDA-approved biologics medicines. – PubMed – NCBI Drug Discov Today. 2015 Apr;20(4):393-8. doi: 10.1016/j.drudis.2014.09.003. Epub 2014 Sep 16. Review Source: An overview of FDA-approved biologics medicines. – PubMed – NCBI
Publication February 1, 2016 by Michael Kinch · Published February 1, 2016 An analysis of FDA-approved drugs for psychiatric disorders. – PubMed – NCBI Drug Discov Today. 2015 Mar;20(3):292-5. doi: 10.1016/j.drudis.2014.08.013. Epub 2014 Sep 6. Source: An analysis of FDA-approved drugs for psychiatric disorders. – PubMed – NCBI
Publication February 1, 2016 by Michael Kinch · Published February 1, 2016 Post-approval fate of pharmaceutical companies. – PubMed – NCBI Drug Discov Today. 2015 Feb;20(2):170-4. doi: 10.1016/j.drudis.2014.10.013. Epub 2014 Nov 4. Source: Post-approval fate of pharmaceutical companies. – PubMed – NCBI
Publication February 1, 2016 by Michael Kinch · Published February 1, 2016 An analysis of FDA-approved drugs: natural products and their derivatives. – PubMed – NCBI Drug Discov Today. 2015 Jan 21. pii: S1359-6446(15)00031-8. doi: 10.1016/j.drudis.2015.01.009. [Epub ahead of print] Source: An analysis of FDA-approved drugs: natural products and their derivatives. – PubMed – NCBI
Publication February 1, 2016 by Michael Kinch · Published February 1, 2016 An analysis of FDA-approved drugs for pain and anesthesia. – PubMed – NCBI Drug Discov Today. 2015 Jan;20(1):3-6. doi: 10.1016/j.drudis.2014.09.002. Epub 2014 Sep 15. Source: An analysis of FDA-approved drugs for pain and anesthesia. – PubMed – NCBI
Publication February 1, 2016 by Michael Kinch · Published February 1, 2016 An analysis of FDA-approved drugs for oncology. – PubMed – NCBI Drug Discov Today. 2014 Dec;19(12):1831-5. doi: 10.1016/j.drudis.2014.08.007. Epub 2014 Aug 27. Source: An analysis of FDA-approved drugs for oncology. – PubMed – NCBI
Publication February 1, 2016 by Michael Kinch · Published February 1, 2016 Trends in pharmaceutical targeting of clinical indications: 1930-2013. – PubMed – NCBI Drug Discov Today. 2014 Nov;19(11):1682-5. doi: 10.1016/j.drudis.2014.05.021. Epub 2014 May 29. Source: Trends in pharmaceutical targeting of clinical indications: 1930-2013. – PubMed – NCBI
Publication February 1, 2016 by Michael Kinch · Published February 1, 2016 An analysis of FDA-approved drugs for infectious disease: HIV/AIDS drugs. – PubMed – NCBI Drug Discov Today. 2014 Oct;19(10):1510-3. doi: 10.1016/j.drudis.2014.05.012. Epub 2014 May 28. Source: An analysis of FDA-approved drugs for infectious disease: HIV/AIDS drugs. – PubMed – NCBI
Publication February 1, 2016 by Michael Kinch · Published February 1, 2016 An analysis of FDA-approved drugs for infectious disease: antibacterial agents. – PubMed – NCBI Drug Discov Today. 2014 Sep;19(9):1283-7. doi: 10.1016/j.drudis.2014.07.005. Epub 2014 Jul 17. Source: An analysis of FDA-approved drugs for infectious disease: antibacterial agents. – PubMed – NCBI
Publication February 1, 2016 by Michael Kinch · Published February 1, 2016 The rise (and decline?) of biotechnology. – PubMed – NCBI Drug Discov Today. 2014 Nov;19(11):1686-90. doi: 10.1016/j.drudis.2014.04.006. Epub 2014 Apr 18. Source: The rise (and decline?) of biotechnology. – PubMed – NCBI